BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2895656)

  • 21. Relationship between the inhibition of azidopine binding to P-glycoprotein by MDR modulators and their efficiency in restoring doxorubicin intracellular accumulation.
    Hu YP; Chapey C; Robert J
    Cancer Lett; 1996 Dec; 109(1-2):203-9. PubMed ID: 9020922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of ATP and drug binding by monoclonal antibodies against P-glycoprotein.
    Georges E; Zhang JT; Ling V
    J Cell Physiol; 1991 Sep; 148(3):479-84. PubMed ID: 1680871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus.
    Yang CP; DePinho SG; Greenberger LM; Arceci RJ; Horwitz SB
    J Biol Chem; 1989 Jan; 264(2):782-8. PubMed ID: 2562956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ATP-binding properties of P glycoprotein from multidrug-resistant KB cells.
    Cornwell MM; Tsuruo T; Gottesman MM; Pastan I
    FASEB J; 1987 Jul; 1(1):51-4. PubMed ID: 2886389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycosylation of P-glycoprotein in a multidrug-resistant KB cell line, and in the human tissues.
    Ichikawa M; Yoshimura A; Furukawa T; Sumizawa T; Nakazima Y; Akiyama S
    Biochim Biophys Acta; 1991 Mar; 1073(2):309-15. PubMed ID: 1672608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the multidrug transporter, P-glycoprotein, in renal and transitional cell carcinomas.
    Nishiyama K; Shirahama T; Yoshimura A; Sumizawa T; Furukawa T; Ichikawa-Haraguchi M; Akiyama S; Ohi Y
    Cancer; 1993 Jun; 71(11):3611-9. PubMed ID: 8098269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine.
    Beck WT; Cirtain MC; Glover CJ; Felsted RL; Safa AR
    Biochem Biophys Res Commun; 1988 Jun; 153(3):959-66. PubMed ID: 2898941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photoaffinity labeling of the organic cation/H+ exchanger in renal brush border membrane vesicles.
    Holohan PD; White KE; Sokol PP; Rebbeor J
    J Biol Chem; 1992 Jul; 267(19):13513-9. PubMed ID: 1352295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells.
    Sehested M; Skovsgaard T; Jensen PB; Demant EJ; Friche E; Bindslev N
    Br J Cancer; 1990 Jul; 62(1):37-41. PubMed ID: 1975202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-(p-azido-3-[125I]iodophenethyl)spiperone binds to specific regions of P-glycoprotein and another multidrug binding protein, spiperophilin, in human neuroblastoma cells.
    Safa AR; Agresti M; Bryk D; Tamai I
    Biochemistry; 1994 Jan; 33(1):256-65. PubMed ID: 7904476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iodomycin and iodipine, a structural analogue of azidopine, bind to a common domain in hamster P-glycoprotein.
    Demmer A; Andreae S; Thole H; Tümmler B
    Eur J Biochem; 1999 Sep; 264(3):800-5. PubMed ID: 10491126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Major photoaffinity drug labeling sites for iodoaryl azidoprazosin in P-glycoprotein are within, or immediately C-terminal to, transmembrane domains 6 and 12.
    Greenberger LM
    J Biol Chem; 1993 May; 268(15):11417-25. PubMed ID: 8098711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photoaffinity labeling of the calcium channel antagonist receptor in the heart of the cardiomyopathic hamster.
    Kuo TH; Johnson DF; Tsang W; Wiener J
    Biochem Biophys Res Commun; 1987 Nov; 148(3):926-33. PubMed ID: 2446613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-glucocorticoid steroid analogues (21-aminosteroids) sensitize multidrug resistant cells to vinblastine.
    Abraham I; Wolf CL; Sampson KE
    Cancer Chemother Pharmacol; 1993; 32(2):116-22. PubMed ID: 8097968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistance.
    Hofmann J; Gekeler V; Ise W; Noller A; Mitterdorfer J; Hofer S; Utz I; Gotwald M; Boer R; Glossmann H
    Biochem Pharmacol; 1995 Mar; 49(5):603-9. PubMed ID: 7887974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of P-glycoprotein with a hydrophobic component of rat urine.
    Charuk JH; Reithmeier RA
    Biochem Biophys Res Commun; 1992 Jul; 186(2):796-802. PubMed ID: 1353959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug resistance dependent on different molecular size P-glycoproteins in Yoshida rat ascites hepatoma cells.
    Miyamoto K; Wakusawa S; Nakamura S
    Biochem Pharmacol; 1992 Mar; 43(5):1143-5. PubMed ID: 1348175
    [No Abstract]   [Full Text] [Related]  

  • 38. The alpha 1-adrenergic photoaffinity probe [125I]arylazidoprazosin binds to a specific peptide of P-glycoprotein in multidrug-resistant cells.
    Safa AR; Agresti M; Tamai I; Mehta ND; Vahabi S
    Biochem Biophys Res Commun; 1990 Jan; 166(1):259-66. PubMed ID: 1967938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog.
    Akiyama S; Cornwell MM; Kuwano M; Pastan I; Gottesman MM
    Mol Pharmacol; 1988 Feb; 33(2):144-7. PubMed ID: 2893251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A molecular basis for multidrug resistance and reversal of the resistance].
    Akiyama S; Yoshimura A; Kikuchi H; Kamiwatari M; Nagata Y; Seto K; Sakota R; Utsunomiya A; Hanada S; Hashimoto S
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1266-72. PubMed ID: 2567148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.